【药物名称】
化学结构式(Chemical Structure):
参考文献No.15700
标题:2-Naphthyl-carbapenem antibacterial agents
作者:DiNinno, F.P.; Greenlee, M.L. (Merck & Co., Inc.)
来源:EP 0466254; JP 1992253980; US 5032587
合成路线图解说明:

Silylation of carboxylic acid (I) by means of tert-butyldimethylsilyl chloride and imidazole in DMF yields derivative (II), which then reacts with allyl glyoxylate (III) in toluene to afford (IV). Treatment of (IV) with SOCl2 and pyridine in THF provides chloro azetidinone (V), which is then converted into (VI) by means of PPh3 and pyridine or 2,6-lutidine in DMF. Ylide acid (VI) is treated with 2-pyridyl chlorothioformate (VII) and Et3N in CH2Cl2 to give derivative (VIII), which is then condensed with the Grignard reagent (XI) and desilylated by means of H2SO4 in MeOH to provide ketophosphorane (XII). Cyclization of (XII) via an internal Wittig reaction by treatment with refluxing p-xylene gives carbapenem (XIII), which is then converted into the corresponding iodide (XIV) via mesylation with MsCl by means of TEA in dichloromethane followed by Finkelstein reaction with NaI in acetone. Reaction of (XIV) with 2-aminopyridine (XV) in acetonitrile provides pyridinium salt (XVI), whose allyl protecting groups are removed by treatment with Pd(PPh3)4, PPh3 in CH2Cl2/EtOAc, followed by 2-ethylhexanoic acid and potassium 2-ethylhexanoate in EtOAc.

合成路线图解说明:

Reagent (XI) can be prepared as follows: Reduction of carboxylic acid (IX) with LiAlH4 in Et2O or BH3 in THF followed by alcohol protection with TBDMSCl in CH2Cl2 in the presence of TEA and DMAP yields silyl ether (X). Derivative (X) is finally converted into Grignard reagent (XI) by means of Mg in THF or, alternatively, by treatment with t-BuLi in THF followed by MgBr2 in CH2Cl2 in the presence of TEA.

参考文献No.553517
标题:2-Naphthylcarbapenems: Broad spectrum antibiotics with enhanced potency against MRSA
作者:Greenlee, M.L.; DiNinno, F.; Herrmann, J.J.; Jaworsky, C.; Muthard, D.A.; Salzmann, T.N.
来源:Bioorg Med Chem Lett 1999,9(19),2893
合成路线图解说明:

Silylation of carboxylic acid (I) by means of tert-butyldimethylsilyl chloride and imidazole in DMF yields derivative (II), which then reacts with allyl glyoxylate (III) in toluene to afford (IV). Treatment of (IV) with SOCl2 and pyridine in THF provides chloro azetidinone (V), which is then converted into (VI) by means of PPh3 and pyridine or 2,6-lutidine in DMF. Ylide acid (VI) is treated with 2-pyridyl chlorothioformate (VII) and Et3N in CH2Cl2 to give derivative (VIII), which is then condensed with the Grignard reagent (XI) and desilylated by means of H2SO4 in MeOH to provide ketophosphorane (XII). Cyclization of (XII) via an internal Wittig reaction by treatment with refluxing p-xylene gives carbapenem (XIII), which is then converted into the corresponding iodide (XIV) via mesylation with MsCl by means of TEA in dichloromethane followed by Finkelstein reaction with NaI in acetone. Reaction of (XIV) with 2-aminopyridine (XV) in acetonitrile provides pyridinium salt (XVI), whose allyl protecting groups are removed by treatment with Pd(PPh3)4, PPh3 in CH2Cl2/EtOAc, followed by 2-ethylhexanoic acid and potassium 2-ethylhexanoate in EtOAc.

合成路线图解说明:

Reagent (XI) can be prepared as follows: Reduction of carboxylic acid (IX) with LiAlH4 in Et2O or BH3 in THF followed by alcohol protection with TBDMSCl in CH2Cl2 in the presence of TEA and DMAP yields silyl ether (X). Derivative (X) is finally converted into Grignard reagent (XI) by means of Mg in THF or, alternatively, by treatment with t-BuLi in THF followed by MgBr2 in CH2Cl2 in the presence of TEA.

参考文献No.605788
标题:Structure-activity relationships in the 2-arylcarbapenem series: Synthesis of 1-methyl-2-arylcarbapenems
作者:Guthikonda, R.N.; Cama, L.D.; Quesada, M.; Woods, M.F.; Salzmann, T.N.; Christensen, B.G.
来源:J Med Chem 1987,30(5),871
合成路线图解说明:

Silylation of carboxylic acid (I) by means of tert-butyldimethylsilyl chloride and imidazole in DMF yields derivative (II), which then reacts with allyl glyoxylate (III) in toluene to afford (IV). Treatment of (IV) with SOCl2 and pyridine in THF provides chloro azetidinone (V), which is then converted into (VI) by means of PPh3 and pyridine or 2,6-lutidine in DMF. Ylide acid (VI) is treated with 2-pyridyl chlorothioformate (VII) and Et3N in CH2Cl2 to give derivative (VIII), which is then condensed with the Grignard reagent (XI) and desilylated by means of H2SO4 in MeOH to provide ketophosphorane (XII). Cyclization of (XII) via an internal Wittig reaction by treatment with refluxing p-xylene gives carbapenem (XIII), which is then converted into the corresponding iodide (XIV) via mesylation with MsCl by means of TEA in dichloromethane followed by Finkelstein reaction with NaI in acetone. Reaction of (XIV) with 2-aminopyridine (XV) in acetonitrile provides pyridinium salt (XVI), whose allyl protecting groups are removed by treatment with Pd(PPh3)4, PPh3 in CH2Cl2/EtOAc, followed by 2-ethylhexanoic acid and potassium 2-ethylhexanoate in EtOAc.

Drug Information Express,Drug R&D,Chemical Database,Patent Search.
Copyright © 2006-2024 Drug Future. All rights reserved.Contact Us